It’s a busy day at the FDA today as panels meet to discuss two new drugs — one to help weight loss and the other to combat drug addiction — and decide whether to approve AstraZeneca’s new blood thinner medication.
Continue reading FDA to Review Arena’s Diet Drug, Alkermes’ Painkiller Addiction Med
FDA to Review Arena’s Diet Drug, Alkermes’ Painkiller Addiction Med originally appeared on DailyFinance on Thu, 16 Sep 2010 07:45:00.
Filed Under: Company News, Health Care, Abbott, Astrazeneca